Christine Katlama - Concepedia

Author

Christine Katlama

Also Known As

A Jary, A Johnson, A. G. Marcelin, A. Karlsson, A. Krivine, A. M. Taburet, A. Provoost, AM Johnson, Aboubacar Alassane Oumar, Adriana Pinto

986

Publications

47.9K

Citations

101

H-Index

198

Concepts

All Affiliations

Sorbonne Université Pitié-Salpêtrière Hospital Inserm Assistance Publique – Hôpitaux de Paris Hôpital Bichat-Claude-Bernard

About

Christine Katlama is an author at Sorbonne Université specializing in medicine, hiv, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	53	143	13.4K
2	Public Health	15	24	2.9K
3	Health Sciences	8	8	743
4	Natural Sciences	3	3	101
5	Nursing	1	1	32

Christine Katlama

457

Publications

41K

Citations

H-Index

Page 1

	Year	Citations
Positive Effects of Combined Antiretroviral Therapy on CD4 <sup>+</sup> T Cell Homeostasis and Function in Advanced HIV Disease Brigitte Autran, Guislaine Carcelain, T. S. Li, Science	1997	1.8K
Isolation of a New Human Retrovirus from West African Patients with AIDS François Clavel, Denise Guétard, Françoise Brun‐Vézinet, Science West African VirusViral EvolutionViral PersistenceMolecular VirologyWest African Patients	1986	1.3K
Decline in the AIDS and death rates in the EuroSIDA study: an observational study Amanda Mocroft, Bruno Ledergerber, Christine Katlama, The Lancet Sexual HealthEpidemiological TrendDeath RatesEpidemiological OutcomeEurosida Study	2003	1.2K
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected Patients Francesca J. Torriani, M. Rodríguez‐Torres, Jürgen K. Rockstroh, New England Journal of Medicine	2004	1.2K
Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients Yves Benhamou, Marie Bochet, Vincent Di Martino, Hepatology	1999	1.2K
Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study Frank van Leth, Praphan Phanuphak, Kiat Ruxrungtham, The Lancet Treatment And PreventionMedicineFirst-line Antiretroviral TherapyClinical TrialsAntiviral Drug Development	2004	683
Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection Roy T. Steigbigel, David A. Cooper, Princy Kumar, New England Journal of Medicine	2008	683
Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia Adriano Lazzarin, Bonaventura Clotet, David A. Cooper, New England Journal of Medicine	2003	651
Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial Beatriz Grinsztejn, Bach-Yen Nguyen, Christine Katlama, The Lancet Multidrug-resistant VirusTreatment And PreventionAntiviral Drug DevelopmentAntiviral TherapyVirology	2007	566
Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort Déborah Konopnicki, Amanda Mocroft, Stéphane De Wit, AIDS	2005	562

Page 1